The main purpose of this legislation, known as the "Lower Drug Costs for Families Act," is to reduce the costs of prescription drugs for families by applying inflation rebates to drugs sold in the commercial market. This means that drug manufacturers will be required to provide rebates if they increase prices faster than the rate of inflation. The legislation aims to make medications more affordable and accessible to consumers. Key provisions of the law include changes to how rebates are calculated for both Part B and Part D drugs under the Social Security Act.